Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The improved cell migration means healing resources arrive faster and in greater numbers at injury sites throughout the body
Research-grade specs Components: GHK-Cu (50 mg) + BPC-157 (10 mg) + TB-500 (10 mg) + KPV (10 mg) Total strength: 80 mg per vial Format: Lyophilized powder, single-vial blend Pathways studied: Matrix remodelling (GHK-Cu), cell migration (BPC-157, TB-500), cytokine signalling (KPV) Studied applications Multi-pathway combination research Comparative single-compound vs combination studies Receptor and cytokine pathway interaction research Copper-peptide and tripeptide comparative research Quality & trust 99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included cGMP manufactured in Dallas, Texas (USA) USA same-day shipping (orders before 2pm CT M-F) Free domestic shipping on orders over $200 Storage & handling Store lyophilized vials refrigerated at 28C, protected from light and heat Reconstitute with bacteriostatic water
joint pain, unexplained rashes, or systemic effects) promptly
Compound Specifications CAS 2226025-84-1 MW 338.36 g/mol Formula C17H14F2N2O3 Purity 99% (HPLC) Documentation & Lab Use Form: Lyophilized research material Documentation: Review the product label, batch records, and applicable laboratory SOPs before accessioning
US$ 24.11
US$ 29.83
US$ 21.83
US$ 25.91
